Form 4: Globus Medical Executive Chairman Exercises Stock Options

Globus Medical's Executive Chairman, David Paul, exercised stock options for 26,042 shares of Class A Common Stock at a price of $24.10 per share.

Summary

• David Paul, the Executive Chairman of Globus Medical, exercised stock options on November 15, 2024.
• The transaction involved 26,042 shares of Class A Common Stock.
• The exercise price was $24.10 per share.
• The options were granted on January 20, 2015, and were fully vested.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for an executive exercising vested stock options, and is common in the medical device industry.

Comparison to Industry Standards

• Stock option exercises are a common form of compensation for executives in publicly traded companies, including those in the medical device sector.
• The vesting period of the options, granted in 2015 and fully vested by 2024, is typical for executive compensation packages.
• Companies like Stryker (SYK) and Medtronic (MDT) also use stock options as part of their executive compensation plans.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it increases the number of shares outstanding.

Key Dates

Keywords

stock options, executive chairman, insider trading, share transaction, Class A Common Stock, Globus Medical, GMED